<Disease><Name>MUCOLIPIDOSIS IV</Name><Synonym>SIALOLIPIDOSIS</Synonym><OMIM><Number>252650</Number><URL>http://omim.org/entry/252650</URL></OMIM><Orphanet><Number>578</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=578</URL></Orphanet><Protein><Number>Mucolipin-1</Number><URL>http://www.uniprot.org/uniprot/Q9GZU1</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>19p13.2</Gene><ICD>E75.1</ICD><Summary>rare ;autosomal recessive ;mutation in the MCOLN1 gene;About 5% of individuals have atypical mucolipidosis IV, often manifest as less severe psychomotor retardation and/or eye findings [Schiffmann R, 2015]</Summary><Symptoms><symtomp><id>2347</id><symptom>anemia</symptom><category>IMMUNE OR HEMATOLOGIC SYSTEM | LABORATORY FINDINGS</category></symtomp><symtomp><id>2211</id><symptom>blindness, visual loss, visual impairment</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2448</id><symptom>corneal clouding</symptom><category>EYES</category></symtomp><symtomp><id>2124</id><symptom>corneal deposits</symptom><category>EYES</category></symtomp><symtomp><id>1948</id><symptom>defect of walking, running, rising or climbing</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1946</id><symptom>dystonia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2336</id><symptom>Electron microscopy [-]</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2261</id><symptom>hyperreflexia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1886</id><symptom>microcephaly (&lt;2 SD for age)</symptom><category>HEAD</category></symtomp><symtomp><id>1941</id><symptom>motor retardation / motor developmental delay</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3357</id><symptom>muscle atrophy / muscular atrophy</symptom><category>MUSCLES</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1739</id><symptom>optic atrophy</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2012</id><symptom>photophobia or photosensitive defect in light-exposed area</symptom><category>SKIN</category></symtomp><symtomp><id>1919</id><symptom>progressive neurologic defect</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3680</id><symptom>psychomotor retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1974</id><symptom>spastic diplegia/quadriplegia/tetraplegia</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2173</id><symptom>strabismus</symptom><category>EYES</category></symtomp></Symptoms><Metabolites><metabolite><id>694</id><name>Creatine kinase</name><specimen>serum</specimen><value>normal/inc</value><min>40.00</min><max>400.00</max><unit>U/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>309</id><name>Creatine kinase</name><specimen>serum</specimen><value>normal/inc</value><min>40.00</min><max>150.00</max><unit>U/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>308</id><name>Creatine kinase</name><specimen>serum</specimen><value>normal/inc</value><min>60.00</min><max>400.00</max><unit>U/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>947</id><name>Creatine kinase</name><specimen>serum</specimen><value>normal/inc</value><min>25.00</min><max>90.00</max><unit>U/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>447</id><name>Iron</name><specimen>serum</specimen><value>decreased</value><min>50.00</min><max>100.00</max><unit>&#181;g/dl</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>1084</id><name>Iron</name><specimen>liver</specimen><value>decreased</value><min>    </min><max>    </max><unit>no data</unit><age>no data</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>7981</id><title>Shared facial phenotype of patients with mucolipidosis type IV: A clinical observation reaffirmed by next generation phenotypin</title><author>Pode-Shakked B,</author><journal>Eur J Med Genetv</journal><year>2020</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>4809</id><title>From mucolipidosis type IV to Ebola: TRPML and two-pore channels at the crossroads of endo-lysosomal trafficking and disease</title><author>Grimm C,</author><journal>Cell Calcium</journal><year>2017</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>4808</id><title>Mucolipidosis IV</title><author>Schiffmann R,</author><journal>GeneReviews&#174; [Internet]</journal><year>2015</year><book /><volume>0</volume><number>0</number><pages /><co_aut>Grishchuk Y, Goldin E</co_aut></literature><literature><id>2262</id><title>Transfer of a mitochondrial DNA fragment to MCOLN1 causes an inherited case of mucolipidosis IV</title><author>Goldin E</author><journal>Hum Mutat</journal><year>2004</year><book /><volume>24</volume><number>6</number><pages>460-465</pages><co_aut>et al.</co_aut></literature><literature><id>2263</id><title>Mucolipin 1: endocytosis and cation channel-a review</title><author>Bach G</author><journal>Pflugers Arch</journal><year>2004</year><book /><volume>0</volume><number>0</number><pages /><co_aut /></literature><literature><id>2264</id><title>Functional links between mucolipin-1 and Ca2+-dependent membrane trafficking in mucolipidosis IV</title><author>LaPlante JM</author><journal>Biochem Biophys Res Commun</journal><year>2004</year><book /><volume>322</volume><number>4</number><pages>1384-1391</pages><co_aut>et al.</co_aut></literature><literature><id>456</id><title>Cultured skin fibroblasts derived from patients with mucolipidosis 4 are auto-fluorescent</title><author>Goldin E</author><journal>Pediatr Res</journal><year>1995</year><book /><volume>37</volume><number>6</number><pages>687-692</pages><co_aut>et al.</co_aut></literature><literature><id>458</id><title>Mucolipidosis IV: morphology and histochemistry of an autopsy case</title><author>Folkerth RD</author><journal>J Neuropathol Exp Neurol</journal><year>1995</year><book /><volume>54</volume><number>2</number><pages>154-164</pages><co_aut>et al.</co_aut></literature><literature><id>457</id><title>Mucolipidosis type IV: accumulation of phospholipids and gangliosides in cultured amniozic cells. A tool for prenatal diagnosis&lt;</title><author>Zeigler M</author><journal>Prenat Diagn</journal><year>1992</year><book /><volume>12</volume><number>12</number><pages>1037-1042</pages><co_aut>et al.</co_aut></literature><literature><id>455</id><title>Mucolipidosis type IV: clinical spectrum and natural history</title><author>Amir N</author><journal>Pediatrics</journal><year>1987</year><book /><volume>79</volume><number>0</number><pages>953-959</pages><co_aut>Zlotogora J, Bach G</co_aut></literature></Literatures></Disease>